Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zalicus Climbs on New Price Target, Market Waking Up to Company's Value?
Seeking Alpha
Monday, March 28, 2011 - 11:41am
tags:
Zalicus, Prednisporin, Sanofi
Novavax 4Q loss narrows on costs
Yahoo/AP
Monday, March 28, 2011 - 10:59am
tags:
Novavax, earnings
The Supreme Court, Generic Labels & Preemption
Pharmalot
Monday, March 28, 2011 - 10:55am
tags:
Supreme Court, generics, preemption
Big Pharma's Next Decade Won't Be Lost
Seeking Alpha
Monday, March 28, 2011 - 10:54am
tags:
Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer
Avanir Pharmaceuticals: Uncovering Nuedexta's Potential Part I
Seeking Alpha
Monday, March 28, 2011 - 9:55am
tags:
Nuedexta, Avanir, PBA
Novartis invests in Chinese vaccine maker
In-Pharmatechnologist
Monday, March 28, 2011 - 9:52am
tags:
China, Novartis, vaccines, Zhejiang Tianyuan Bio-Pharmaceutical
3 Biotech Stocks on Our ASCO Watchlist
Seeking Alpha
Monday, March 28, 2011 - 9:49am
tags:
ASCO, Array Biopharma, Spectrum Pharmaceuticals, Ariad Pharmaceuticals
Is Approval of Bristol-Myers Squibb's Yervoy Start of New Chapter at FDA?
Minyanville
Monday, March 28, 2011 - 9:48am
tags:
FDA, Bristol-Myers Squibb, Yervoy, ipilimumab, melanoma
AstraZeneca lifts earnings guidances after tax deal
Marketwatch
Monday, March 28, 2011 - 9:47am
tags:
AstraZeneca, guidance
Making Clinical Trials Less of a Tribulation
WSJ Online
Monday, March 28, 2011 - 9:46am
tags:
clinical trials
First China Pharma well on way to $3m funding
Wired VC
Sunday, March 27, 2011 - 12:18pm
tags:
First China Pharma
Arch Pharmalabs files IPO papers with SEBI
MoneyControl, India
Sunday, March 27, 2011 - 12:13pm
tags:
Arch Pharmalabs, bipolar disorder
Top 5 Pharmaceuticals Paying Excellent Dividends
Seeking Alpha
Sunday, March 27, 2011 - 12:10pm
tags:
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer
Cephalon Beefs Up Cancer Pipeline, Sanofi Bolsters Collaborative Activities
Seeking Alpha
Sunday, March 27, 2011 - 12:09pm
tags:
Cephalon, Sanofi, Gemin X, obatoclax, small cell lung cancer, Fovea
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Seeking Alpha
Sunday, March 27, 2011 - 11:39am
tags:
ipilimumab, monoclonal antibodies, immunotherapy, Yervoy, Bristol-Myers Squibb, melanoma
Coming: Radically Shrunken Pfizer?
Barron's
Saturday, March 26, 2011 - 3:38pm
tags:
Pfizer
Federal Circuit: Cross-appeal by Apotex an 'egregious' attempt to 'game the system'
Law.com
Saturday, March 26, 2011 - 3:35pm
tags:
Apotex, Sanofi, Taxotere, lawsuits, Hospira
Urigen Operational Progress Report
The Street
Saturday, March 26, 2011 - 10:23am
tags:
Urigen Pharmaceuticals
Biostar Pharmaceuticals (BSPM) Posts Solid Q4, FY Earnings
International Business Times
Saturday, March 26, 2011 - 10:21am
tags:
Biostar Pharmaceuticals
Watson Confirms OxyContin® Patent Challenge
PR NewsWire
Saturday, March 26, 2011 - 10:20am
tags:
Watson Pharmaceuticals, oxycontin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.